Business Description
Talis Biomedical Corp
NAICS : 339112
SIC : 3845
ISIN : US87424L2079
Share Class Description:
TLIS: Ordinary SharesDescription
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 98.66 | |||||
12-1 Month Momentum % | 127.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -13411.67 | |||||
OCF Margin % | -13419.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TLIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Talis Biomedical Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.3 | ||
| EPS (TTM) ($) | -28.02 | ||
| Beta | 0.8339 | ||
| 3-Year Sharpe Ratio | -0.08 | ||
| 3-Year Sortino Ratio | -0.13 | ||
| Volatility % | 76.8 | ||
| 14-Day RSI | 98.66 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 2.84 | ||
| 12-1 Month Momentum % | 127.2 | ||
| 52-Week Range ($) | 1.15 - 2.84 | ||
| Shares Outstanding (Mil) | 1.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Talis Biomedical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Talis Biomedical Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 137 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 | In 29 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 29 days | ||
| Annual report for 2025 | 2026-07-20 | In 4 days | ||
| General meeting for 2025 | 2026-07-20 | In 4 days | ||
| Second quarter earnings conference call for 2024 | 2024-08-10 16:30 | 3.76 (-5.29%) | ||
| Second quarter earnings results for 2024 | 2024-08-10 | 3.76 (-5.29%) | ||
| 0.0666667:1 Stock Split | 2023-07-06 | 7.47 (+5.98%) |
Show
Entries
Talis Biomedical Corp Frequently Asked Questions
What is Talis Biomedical Corp(TLIS)'s stock price today?
The current price of TLIS is $2.84. The 52 week high of TLIS is $2.84 and 52 week low is $1.15.
When is next earnings date of Talis Biomedical Corp(TLIS)?
The next earnings date of Talis Biomedical Corp(TLIS) is 2026-08-14 Est..
Does Talis Biomedical Corp(TLIS) pay dividends? If so, how much?
Talis Biomedical Corp(TLIS) does not pay dividend.
Guru Commentaries on OTCPK:TLIS
No articles.
Press Release
Articles on Talis Biomedical Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers